Residual pharmaceutically active compounds (PhAcs) in aquatic environment - status, toxicity and kinetics: a review

被引:62
作者
Li, Z. H. [1 ]
Randak, T. [1 ]
机构
[1] Univ S Bohemia Ceske Budejovice, Res Inst Fish Culture & Hydrobiol, Dept Aquat Toxicol & Fish Dis, Vodnany 38925, Czech Republic
关键词
residual PhACs; aquatic environment; status; toxicity; kinetics; SALMON SALMO-SALAR; SINGLE-DOSE PHARMACOKINETICS; VITRO ANTIBACTERIAL ACTIVITY; OXOLINIC ACID-ESTER; SEWAGE-TREATMENT PLANTS; PERSONAL CARE PRODUCTS; EEL ANGUILLA-ANGUILLA; GILTHEAD SEA BREAM; COD GADUS-MORHUA; RAINBOW-TROUT;
D O I
10.17221/97/2009-VETMED
中图分类号
S85 [动物医学(兽医学)];
学科分类号
0906 ;
摘要
Awareness of residual pharmaceutically active compounds (PhACs) in aquatic ecosystems is growing as research into these pollutants increases and analytical detection techniques improve. For most pharmaceuticals analyzed, the effects on aquatic organisms have usually been investigated by toxic assays in the laboratory. However, little is known about integral analysis of pharmacokinetics in aquatic organisms and specific relations between pharmacokinetic parameters and influence factors. Moreover, the influence of the organisms involved and numerous other external factors complicates development of standard tests for environmental evaluation. Current knowledge about residual pharmaceuticals in the aquatic environment, including status, toxic effects, and pharmacokinetics in aquatic organisms, are reviewed. Based on the above, we identify major gaps in the current knowledge and some directions for future research, such as improvement of techniques to remove residual pharmaceuticals from wastewater, and the establishment of standard pharmaceutical modes of action.
引用
收藏
页码:295 / 314
页数:20
相关论文
共 107 条
[1]   Comparative pharmacokinetics and bioavailability of oxytetracycline in rainbow trout and chinook salmon [J].
Abedini, S ;
Namdari, R ;
Law, FCP .
AQUACULTURE, 1998, 162 (1-2) :23-32
[2]   PHARMACOKINETICS OF SULFADIMETHOXINE IN THE LOBSTER, HOMARUS-AMERICANUS, FOLLOWING INTRAPERICARDIAL ADMINISTRATION [J].
BARRON, MG ;
GEDUTIS, C ;
JAMES, MO .
XENOBIOTICA, 1988, 18 (03) :269-276
[3]  
BARRON MG, 1991, DRUG METAB DISPOS, V19, P163
[4]  
BJORKLUND HV, 1991, XENOBIOTICA, V21, P1511
[5]   Fish as model in pharmacological and biological research [J].
Bolis, CL ;
Piccolella, M ;
Dalla Valle, AZ ;
Rankin, JC .
PHARMACOLOGICAL RESEARCH, 2001, 44 (04) :265-280
[6]   The stress response in fish [J].
Bonga, SEW .
PHYSIOLOGICAL REVIEWS, 1997, 77 (03) :591-625
[7]   DISPOSITION OF FLUMEQUINE IN PLASMA OF EUROPEAN EEL (ANGUILLA-ANGUILLA) AFTER A SINGLE INTRAMUSCULAR INJECTION [J].
BOON, JH ;
NOUWS, JMF ;
VANDERHEIJDEN, MHT ;
BOOMS, GHR ;
DEGEN, M .
AQUACULTURE, 1991, 99 (3-4) :213-223
[8]   Pharmaceuticals in the aquatic environment - a comparison of risk assessment strategies [J].
Bound, JP ;
Voulvoulis, N .
CHEMOSPHERE, 2004, 56 (11) :1143-1155
[9]   Aquatic ecotoxicology of fluoxetine [J].
Brooks, BW ;
Foran, CM ;
Richards, SM ;
Weston, J ;
Turner, PK ;
Stanley, JK ;
Solomon, KR ;
Slattery, M ;
La Point, TW .
TOXICOLOGY LETTERS, 2003, 142 (03) :169-183
[10]   Contaminant effects on the teleost fish thyroid [J].
Brown, SB ;
Adams, BA ;
Cyr, DG ;
Eales, JG .
ENVIRONMENTAL TOXICOLOGY AND CHEMISTRY, 2004, 23 (07) :1680-1701